Abstract:BackgroundThe heterogeneity of lung adenocarcinoma (LUAD) plays a vital role in determining the development of cancer and therapeutic sensitivity and significantly hinders the clinical treatment of LUAD.ObjectiveTo elucidate the cellular composition and reveal previously uncharacterised tumour microenvironment in LUAD using single-cell RNA-sequencing (scRNA-seq).MethodsTwo scRNA-seq datasets with 106 829 high-quality cells from 34 patients including 11 normal, 9 early (stage I and II) and 14 advanced (stage III and IV) LUAD were integrated and clustered to explore diagnostic and therapeutic cell populations and their biomarkers for diverse stages of LUAD. Three independent bulk RNA-seq datasets were used to validate the results from scRNA-seq analysis. The expression of marker genes for specific cell types in early and advanced LUAD was verified by immunohistochemistry (IHC).ResultsComprehensive cluster analysis identified that S100P+ epithelial and SPP1+ macrophage, positively related to poor outcomes, were preferentially enriched in advanced stage. Although the accumulation of KLRB1+CD8+ T cell and IGHA1+/IGHG1+ plasma cell both significantly associated the favourable prognosis, we also found KLRB1+CD8+ T cell decreased in advanced stage while IGHA1+/IGHG1+ plasma cells were increased. Cell-cell communication analysis showed that SPP1+ macrophage could interact with most of CD8+ subclusters through SPP1-CD44 axis. Furthermore, based on three independent bulk RNA-seq datasets, we built risk model with nine marker genes for specific cell subtypes and conducted deconvolution analysis, both supporting our results from scRNA-seq data. We finally validated the expression of four marker genes in early and advanced LUAD by IHC.ConclusionOur analyses highlight the molecular dynamics of LUAD epithelial and microenvironment and provide new targets to improve LUAD therapy.

[Advancements in Single-cell RNA Sequencing Technology in the Study of the Tumor Microenvironment in Lung Cancer]

Applications of single-cell analysis in immunotherapy for lung cancer: Current progress, new challenges and expectations

Research progress and the prospect of using single-cell sequencing technology to explore the characteristics of the tumor microenvironment

Single-Cell RNA Sequencing in Lung Cancer: Revealing Phenotype Shaping of Stromal Cells in the Microenvironment

Application of single-cell sequencing to the research of tumor microenvironment

Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing

Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment

How Single-Cell Techniques Help Us Look into Lung Cancer Heterogeneity and Immunotherapy

Unraveling the tumor immune microenvironment of lung adenocarcinoma using single-cell RNA sequencing

Integrative insights and clinical applications of single-cell sequencing in cancer immunotherapy

P02.05 Comprehensive Profiling of Tumor Heterogeneity and Its Microenvironment in Advanced Non-Small Cell Lung Cancer at Single Cell Resolution

Unravelling immune microenvironment features underlying tumor progression in the single-cell era

Deciphering the Immune–Tumor Interplay During Early-Stage Lung Cancer Development via Single-Cell Technology

High-throughput single-cell sequencing in cancer research

Advances in single-cell RNA sequencing and its applications in cancer research

Single-cell RNA sequencing reveals microenvironmental infiltration in non-small cell lung cancer with different responses to immunotherapy

Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma

Applications of single-cell sequencing in cancer research: progress and perspectives

Progress and Clinical Application of Single-Cell Transcriptional Sequencing Technology in Cancer Research

Extensive exploration of T cell heterogeneity in cancers by single cell sequencing.

Research progress of single cell sequencing technique in predicting the immunotherapeutic efficacy of lung cancer